Harnessing Bioinformatics, Genomics & AI to Advance Digital Pathology & Unravel the Tumor Microenvironment Across Patient Subtypes
Time: 12:00 pm
day: Conference Day One
Details:
- How can H&E-based digital pathology, integrated with genomics and bioinformatics, provide deeper insights into the tumor microenvironment and reveal actionable differences across patient subtypes?
- What are the key challenges and opportunities in combining spatial biology, NGS, and histopathology data to define more precise biomarkers and stratify patients in clinical trials?
- How can biopharma organizations develop the cross-functional infrastructure needed to scale AI-driven digital pathology innovations from discovery to clinical application and therapeutic impact?